Cargando…
Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries
BACKGROUND: Following the amendment of the Pharmaceutical Affairs Law in Japan in 2003 researchers were permitted to begin investigator-initiated trials (IITs). In subsequent years, however, the number of IITs remained low. In other countries in Asia as well as in Europe, North America, and South Af...
Autor principal: | Ito, Tatsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744062/ https://www.ncbi.nlm.nih.gov/pubmed/26848574 http://dx.doi.org/10.1371/journal.pone.0148455 |
Ejemplares similares
-
Computerized monitoring of COVID-19 trials, studies and registries in ClinicalTrials.gov registry
por: Mayer, Craig S., et al.
Publicado: (2020) -
An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov
por: Keezhupalat, Shruthi Muralidharan, et al.
Publicado: (2016) -
The Egyptian clinical trials’ registry profile: Analysis of three trial registries (International Clinical Trials Registry Platform, Pan-African Clinical Trials Registry and clinicaltrials.gov)
por: Zeeneldin, Ahmed A., et al.
Publicado: (2016) -
Characteristics of Phase IV Clinical Trials in Oncology: An Analysis Using the ClinicalTrials.gov Registry Data
por: Henry, Brandon Michael, et al.
Publicado: (2023) -
Characteristics of clinical trial websites: information distribution between ClinicalTrials.gov and 13 primary registries in the WHO registry network
por: Ogino, Daisuke, et al.
Publicado: (2014)